COMMUNITY ENGAGEMENT & RESEARCH LITERACY
Online TB Research Curriculum
Check out the new online curriculum on the research and development of new TB tools (diagnostics, drugs, and vaccines). This free course, hosted on the TeachMeTB platform, has been specifically designed for and with advocates and affected communities to provide a base of knowledge in TB research and build capacity to advocate for the new tools and ambition that will be needed to #EndTB by 2030.
Learners who complete the full course are eligible for a certificate.
The full TB Research Literacy curriculum includes modules on Research Fundamentals, Vaccines, Drugs, and Diagnostics. A coursebook accompanies the learning modules, with activities to practice and reinforce your learning. You will work on an advocacy plan as you work your way through the course, so that by the time you complete the course you will be ready to put what you learned into action!
The full course and materials are available in English. The video lessons from the Vaccines Module are available with subtitles in English, Brazilian Portuguese, French, Russian, and Spanish. You can view them below or as part of the full online course.
Select a lesson below. When the video opens, click on the "cc" icon in the bottom right corner and select "English."
- Lesson 1: Why do we need new TB vaccines?
- Lesson 2 : What are the funding limitations that are slowing progress in TB vaccine research and development?
- Lesson 4 - Part 1: How are TB vaccines developed?
- Lesson 4 - Part 2 : How are TB vaccines developed?
- Lesson 4 - Part 3: How are TB vaccines developed?
- Lesson 5 : What are promising new developments in TB vaccines research?
- Lesson 7 : What are the potential impacts of approving new vaccines and making them accessible?
- Lesson 8 : What access considerations doe we need to address to successfully introduce new TB vaccines?
- Lesson 9 : How can you effectively communicate the need for new TB vaccines?
Contact us if you have resources related to community engagement and literacy for TB and vaccine research that you would like to share.